James M Daly - Net Worth and Insider Trading

James M Daly Net Worth

The estimated net worth of James M Daly is at least $2 Million dollars as of 2024-11-13. James M Daly is the Director of Halozyme Therapeutics Inc and owns about 20,503 shares of Halozyme Therapeutics Inc (HALO) stock worth over $1 Million. James M Daly is the Director of Madrigal Pharmaceuticals Inc and owns about 1,198 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $406,422. James M Daly is also the EVP, Chief Commercial Officer of Incyte Corp and owns about 3,521 shares of Incyte Corp (INCY) stock worth over $283,757. Besides these, James M Daly also holds ACADIA Pharmaceuticals Inc (ACAD) . Details can be seen in James M Daly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James M Daly has not made any transactions after 2024-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James M Daly

To

James M Daly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James M Daly owns 6 companies in total, including Halozyme Therapeutics Inc (HALO) , ACADIA Pharmaceuticals Inc (ACAD) , and Madrigal Pharmaceuticals Inc (MDGL) among others .

Click here to see the complete history of James M Daly’s form 4 insider trades.

Insider Ownership Summary of James M Daly

Ticker Comapny Transaction Date Type of Owner
HALO Halozyme Therapeutics Inc 2023-08-14 director
ACAD ACADIA Pharmaceuticals Inc 2020-05-11 director
MDGL Madrigal Pharmaceuticals Inc 2024-04-02 director
LIMIT LIMIT 2021-07-01 director
LIMIT LIMIT 2014-06-20 director
LIMIT LIMIT 2015-06-23 Exec. VP & Chief Comm. Officer

James M Daly Latest Holdings Summary

James M Daly currently owns a total of 4 stocks. Among these stocks, James M Daly owns 20,503 shares of Halozyme Therapeutics Inc (HALO) as of August 14, 2023, with a value of $1 Million and a weighting of 63.92%. James M Daly owns 1,198 shares of Madrigal Pharmaceuticals Inc (MDGL) as of April 2, 2024, with a value of $406,422 and a weighting of 21.25%. James M Daly also owns 3,521 shares of Incyte Corp (INCY) as of June 23, 2015, with a value of $283,757 and a weighting of 14.83%. The other 1 stocks ACADIA Pharmaceuticals Inc (ACAD) have a combined weighting of 0% among all his current holdings.

Latest Holdings of James M Daly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HALO Halozyme Therapeutics Inc 2023-08-14 20,503 59.64 1,222,799
MDGL Madrigal Pharmaceuticals Inc 2024-04-02 1,198 339.25 406,422
INCY Incyte Corp 2015-06-23 3,521 80.59 283,757
ACAD ACADIA Pharmaceuticals Inc 2020-05-11 0 17.94 0

Holding Weightings of James M Daly


James M Daly Form 4 Trading Tracker

According to the SEC Form 4 filings, James M Daly has made a total of 3 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 20,000 shares on August 14, 2023, which brought James M Daly around $874,600.

According to the SEC Form 4 filings, James M Daly has made a total of 1 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 32,489 shares on April 2, 2024, which brought James M Daly around $8 Million.

According to the SEC Form 4 filings, James M Daly has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 11,691 shares on June 23, 2015, which brought James M Daly around $1 Million.

More details on James M Daly's insider transactions can be found in the Insider Trading History of James M Daly table.

Insider Trading History of James M Daly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James M Daly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James M Daly Ownership Network

Ownership Network List of James M Daly

No Data

Ownership Network Relation of James M Daly

Insider Network Chart

James M Daly Owned Company Details

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

James M Daly is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, James M Daly made 1 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 20,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .

In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Halozyme Therapeutics Inc Insider Transactions

No Available Data

James M Daly Mailing Address

Above is the net worth, insider trading, and ownership report for James M Daly. You might contact James M Daly via mailing address: Incyte Corporation Experimental Station, Rte 141 & Henry Clay Rd. Bldg E336, Wilmington De 19880.